Financial Ratios

DECIPHER LABS LTD.

NSE : NABSE : 524752ISIN CODE : INE643N01012Industry : Pharmaceuticals & DrugsHouse : MNC
BSE14.770.1 (+0.68 %)
PREV CLOSE ( ) 14.67
OPEN PRICE ( ) 14.71
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 40359
TODAY'S LOW / HIGH ( )14.50 15.80
52 WK LOW / HIGH ( ) 1225.75
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-2.590.360.100.170.47
   CEPS(Rs)-2.530.410.140.170.47
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)8.8211.4111.0510.963.12
   Tax Rate(%)0.81-0.704.18-0.300.03
Margin Ratios
   Core EBITDA Margin(%)-45.4636.631.5911.095.44
   EBIT Margin(%)-325.7936.2112.1211.775.56
   Pre Tax Margin(%)-325.7936.2110.2911.775.56
   PAT Margin (%)-323.1536.469.8611.805.56
   Cash Profit Margin (%)-316.0641.5314.1112.055.57
Performance Ratios
   ROA(%)-25.453.130.831.928.57
   ROE(%)-25.633.180.872.4816.33
   ROCE(%)-25.843.141.052.4015.42
   Asset Turnover(x)0.080.090.080.161.54
   Sales/Fixed Asset(x)2.412.704.7223.73892.25
   Working Capital/Sales(x)8.220.390.390.562.78
Efficiency Ratios
   Fixed Capital/Sales(x)0.420.370.210.040.00
   Receivable days77.24116.25110.08411.7297.55
   Inventory Days0.0016.3267.8682.0811.27
   Payable days99.11989.62113.81
Valuation Parameters
   PER(x)0.00148.39351.19113.3253.06
   PCE(x)-5.60130.28245.35111.0152.98
   Price/Book(x)1.614.643.031.728.01
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)17.6254.0634.7413.522.97
   EV/Core EBITDA(x)-41.99130.96212.15112.5153.29
   EV/EBIT(x)-5.41149.29286.57114.8653.37
   EV/CE(x)1.594.602.971.653.45
   M Cap / Sales17.6954.1134.6213.372.95
Growth Ratio
   Net Sales Growth(%)-18.051.27-31.44-79.01567.23
   Core EBITDA Growth(%)-183.33155.32-6.55-54.71107.02
   EBIT Growth(%)-837.33202.54-29.37-55.57106.69
   PAT Growth(%)-826.28274.64-42.74-55.43106.63
   EPS Growth(%)-826.28274.64-42.74-64.69106.63
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.010.020.06
   Current Ratio(x)2.1532.3611.775.361.73
   Quick Ratio(x)2.1531.8111.584.811.63
   Interest Cover(x)6.61
   Total Debt/Mcap(x)0.000.000.000.010.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.